Viridian Therapeutics Statistics

Total Valuation

VRDN has a market cap or net worth of $1.78 billion. The enterprise value is $1.39 billion.

Market Cap	1.78B
Enterprise Value	1.39B

Important Dates

The next estimated earnings date is Monday, November 11, 2024, after market close.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

VRDN has 76.35 million shares outstanding. The number of shares has increased by 36.58% in one year.

Current Share Class	76.35M
Shares Outstanding	76.35M
Shares Change (YoY)	+36.58%
Shares Change (QoQ)	+4.51%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	83.58%
Float	68.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	5,412.56
PB Ratio	4.43
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4,842.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.82, with a Debt / Equity ratio of 0.04.

Current Ratio	15.82
Quick Ratio	15.54
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-92.88

Financial Efficiency

Return on equity (ROE) is -53.97% and return on invested capital (ROIC) is -35.84%.

Return on Equity (ROE)	-53.97%
Return on Assets (ROA)	-33.45%
Return on Capital (ROIC)	-35.84%
Revenue Per Employee	$3,064
Profits Per Employee	-$2.43M
Employee Count	94
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.72% in the last 52 weeks. The beta is 1.11, so VRDN's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	+48.72%
50-Day Moving Average	21.22
200-Day Moving Average	17.01
Relative Strength Index (RSI)	49.91
Average Volume (20 Days)	728,354

Short Selling Information

The latest short interest is 9.79 million, so 12.83% of the outstanding shares have been sold short.

Short Interest	9.79M
Short Previous Month	10.15M
Short % of Shares Out	12.83%
Short % of Float	14.30%
Short Ratio (days to cover)	7.85

Income Statement

In the last 12 months, VRDN had revenue of $288,000 and -$228.06 million in losses. Loss per share was -$4.18.

Revenue	288,000
Gross Profit	-164.28M
Operating Income	-250.79M
Pretax Income	-228.06M
Net Income	-228.06M
EBITDA	-250.21M
EBIT	-250.79M
Loss Per Share	-$4.18

Full Income Statement

Balance Sheet

The company has $571.37 million in cash and $22.61 million in debt, giving a net cash position of $548.76 million or $7.19 per share.

Cash & Cash Equivalents	571.37M
Total Debt	22.61M
Net Cash	548.76M
Net Cash Per Share	$7.19
Equity (Book Value)	529.34M
Book Value Per Share	5.16
Working Capital	544.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$168.26 million and capital expenditures -$556,000, giving a free cash flow of -$168.82 million.

Operating Cash Flow	-168.26M
Capital Expenditures	-556,000
Free Cash Flow	-168.82M
FCF Per Share	-$2.21

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-87,078.13%
Pretax Margin	-79,185.76%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-58,618.06%

Dividends & Yields

VRDN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.58%
Shareholder Yield	-36.58%
Earnings Yield	-13.08%
FCF Yield	-9.68%

Analyst Forecast

The average price target for VRDN is $36.56, which is 57.25% higher than the current price. The consensus rating is "Buy".

Price Target	$36.56
Price Target Difference	57.25%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	381.74%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 13, 2020. It was a reverse split with a ratio of 0.0666666:1.

Last Split Date	Nov 13, 2020
Split Type	Reverse
Split Ratio	0.0666666:1

Scores

VRDN has an Altman Z-Score of 7.38 and a Piotroski F-Score of 2.

Altman Z-Score	7.38
Piotroski F-Score	2